Yıl: 2023 Cilt: 15 Sayı: 1 Sayfa Aralığı: 77 - 88 Metin Dili: İngilizce DOI: 10.4274/jcrpe.galenos.2022.2022-8-19 İndeks Tarihi: 25-05-2023

Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone

Öz:
Objective: Reports on the association between growth hormone (GH) therapy and cardiovascular risk factors in children are limited. This study aimed to evaluate carotid intima-media thickness (cIMT) in children treated with recombinant human GH (rhGH) and assess the effects of rhGH therapy and changes in serum carbohydrate metabolism, lipid profile and adipocytokines on cIMT. Methods: Seventy-one isolated idiopathic GH deficiency (GHD) children and 44 age- and sex-matched healthy controls were enrolled in this study. The study group was divided into two subgroups according to insulin resistance (IR) on oral glucose tolerance tests. Insulin secretion [homeostatic model assessment (HOMA) B, total insulin] and sensitivity (HOMA-IR, QUICKI, Matsuda) indices were calculated. cIMT was measured and the standard deviation scores (SDS) were calculated. Associations between cIMT-SDS and insulin secretion and sensitivity indices, serum lipid levels, adipocytokines (leptin, resistin, ghrelin), and other rhGH treatment-related factors were evaluated. Results: cIMT-SDS was increased in GHD children treated with rhGH compared to the controls [0.02 (2.27) vs. -1.01 (1.63), p=0.003]. cIMT-SDS did not differ between those children on rhGH treatment with or without IR. High cIMT-SDS was significantly associated with higher serum ghrelin levels and lower serum high density lipoprotein (HDL) levels (β=0.491, p=0.001 and β=-0.027, p=0.017), but not with BMI-SDS, blood pressure, insulin secretion and sensitivity indices, or the dose and duration of rhGH therapy. Conclusion: Our findings showed that GHD children treated with rhGH have increased cIMT. Alterations in carbohydrate metabolism were not associated with cIMT in children treated with rhGH. GH therapy per se appears to be associated with this increased cIMT but causality should be elucidated in further studies. cIMT also appears to be associated with higher ghrelin and lower HDL levels.
Anahtar Kelime: Recombinant growth hormone carotis intima-media thickness adipocytokines carbohydrate metabolism

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Palmeiro CR, Anand R, Dardi IK, Balasubramaniyam N, Schwarcz MD, Weiss IA. Growth hormone and the cardiovascular system. Cardiol Rev 2012;20:197-207.
  • Tidblad A, Bottai M, Kieler H, Albertsson-Wikland K, Sävendahl L. Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity. JAMA Pediatr 2021;175:e205199. Epub 2021 Feb 1
  • Clayton RN. Cardiovascular function in acromegaly. Endocr Rev 2003;24:272-277.
  • Găloiu S, Jurcuţ R, Vlădaia A, Florian A, Purice M, Popescu BA, Ginghină C, Coculescu M. Structural and functional changes of carotid wall properties in patients with acromegaly are not restored after 1 year of GH/IGF1 normalization. Exp Clin Endocrinol Diabetes 2012;120:238- 243. Epub 2012 Mar 16
  • Murray RD, Wieringa G, Lawrance JA, Adams JE, Shalet SM. Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima-medial thickness. Clin Endocrinol (Oxf) 2010;73:508-515.
  • Carel JC, Ecosse E, Landier F, Meguellati-Hakkas D, Kaguelidou F, Rey G, Coste J. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study. J Clin Endocrinol Metab 2012;97:416-425. Epub 2012 Jan 11
  • Poidvin A, Touzé E, Ecosse E, Landier F, Béjot Y, Giroud M, Rothwell PM, Carel JC, Coste J. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood. Neurology 2014;83:780- 786. Epub 2014 Aug 13
  • Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS, Cheung PT, Choong CSY, Cohen LE, Cohen P, Dauber A, Deal CL, Gong C, Hasegawa Y, Hoffman AR, Hofman PL, Horikawa R, Jorge AAL, Juul A, Kamenický P, Khadilkar V, Kopchick JJ, Kriström B, Lopes MLA, Luo X, Miller BS, Misra M, Netchine I, Radovick S, Ranke MB, Rogol AD, Rosenfeld RG, Saenger P, Wit JM, Woelfle J. Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective. Horm Res Paediatr 2019;92:1-14. Epub 2019 Sep 12
  • Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, Rossi WC, Feudtner C, Murad MH; Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr 2016;86:361-397. Epub 2016 Nov 25
  • Stochholm K, Kiess W. Long-term safety of growth hormone-A combined registry analysis. Clin Endocrinol (Oxf) 2018;88:515-528. Epub 2017 Nov 20
  • Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS; American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008;21:93-111; quiz 189-190. Erratum in: J Am Soc Echocardiogr 2008;21:376.
  • Van De Maele K, Devlieger R, Gies I. In utero programming and early detection of cardiovascular disease in the offspring of mothers with obesity. Atherosclerosis 2018;275:182-195. Epub 2018 Jun 9
  • Reynolds RM, Allan KM, Raja EA, Bhattacharya S, McNeill G, Hannaford PC, Sarwar N, Lee AJ, Bhattacharya S, Norman JE. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years. BMJ 2013;347:f4539.
  • Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, Steinberger J, McCrindle B; American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 2009;54:919-950. Erratum in: Hypertension 2010;56:e36. Epub 2009 Sep 3
  • Doyon A, Kracht D, Bayazit AK, Deveci M, Duzova A, Krmar RT, Litwin M, Niemirska A, Oguz B, Schmidt BM, Sözeri B, Querfeld U, Melk A, Schaefer F, Wühl E; 4C Study Consortium. Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension 2013;62:550-556. Epub 2013 Jul 1
  • Rothermel J, Knop C, Lass N, Toschke C, Wunsch R, Reinehr T. Carotid Intima-Media Thickness in Children Treated with Growth Hormone: A Follow-Up Study over Three Years. Horm Res Paediatr 2017;87:73-80. Epub 2017 Jan 10
  • Knop C, Wolters B, Lass N, Wunsch R, Reinehr T. Carotid intima- media thickness in children treated with growth hormone. J Pediatr Endocrinol Metab 2015;28:985-991.
  • Chen M, Gan D, Luo Y, Rampersad S, Xu L, Yang S, Li N, Li H. Effect of recombinant human growth hormone therapy on blood lipid and carotid intima-media thickness in children with growth hormone deficiency. Pediatr Res 2018;83:954-960. Epub 2018 Jan 17
  • Binay C, Simsek E, Yıldırım A, Kosger P, Demiral M, Kılıç Z. Growth hormone and the risk of atherosclerosis in growth hormone-deficient children. Growth Horm IGF Res 2015;25:294-297. Epub 2015 Aug 12
  • McGrath S, Morris M, Bouloux PM. Growth hormone deficiency and atherosclerosis--is there a link? Growth Horm IGF Res 1999;9 Suppl A:9-13.
  • Møller N, Jørgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 2009;30:152- 177. Epub 2009 Feb 24
  • Cutfield WS, Wilton P, Bennmarker H, Albertsson-Wikland K, Chatelain P, Ranke MB, Price DA. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth- hormone treatment. Lancet 2000;355:610-613.
  • Jørgensen JO, Pedersen SA, Thuesen L, Jørgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;1:1221-1225.
  • Bratusch-Marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 1982;55:973-982.
  • Ciresi A, Giordano C. Glucose Metabolism in Children With Growth Hormone Deficiency. Front Endocrinol (Lausanne) 2018;9:321.
  • Ciresi A, Amato MC, Giordano C. Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment. J Endocrinol Invest 2015;38:351-359. Epub 2014 Oct 2
  • Pellegrin MC, Michelon D, Faleschini E, Germani C, Barbi E, Tornese G. Glucose Metabolism Evaluated by Glycated Hemoglobin and Insulin Sensitivity Indices in Children Treated with Recombinant Human Growth Hormone. J Clin Res Pediatr Endocrinol 2019;11:350-357. Epub 2019 Mar 1
  • Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 2000;85:3990- 3993.
  • Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, Bas F. Growth references for Turkish children aged 6 to 18 years. Acta Paediatr 2006;95:1635-1641. Erratum in: Acta Paediatr 2007;96:324.
  • Hatipoglu N, Ozturk A, Mazicioglu MM, Kurtoglu S, Seyhan S, Lokoglu F. Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents. Eur J Pediatr 2008;167:383-389. Epub 2007 May 9
  • Rikken B, Wit JM. Prepubertal height velocity references over a wide age range. Arch Dis Child 1992;67:1277-1280.
  • Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
  • Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM; Subcommıttee On Screenıng And Management Of Hıgh Blood Pressure In Chıldren. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017;140:e20171904. Erratum in: Pediatrics 2017. Erratum in: Pediatrics 2018;142. Epub 2017 Aug 21
  • Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, Groop LC. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 2000;49:975-980.
  • American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41:S13-S27.
  • Kurtoğlu S, Hatipoğlu N, Mazıcıoğlu M, Kendirici M, Keskin M, Kondolot M. Insulin resistance in obese children and adolescents: HOMA-IR cut- off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2010;2:100-106. Epub 2010 Aug 2
  • Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 2003;17:305-322.
  • Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.
  • Zannolli R, Rebeggiani A, Chiarelli F, Morgese G. Hyperinsulinism as a marker in obese children. Am J Dis Child 1993;147:837-841.
  • Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012;34:290-296. Epub 2012 Nov 1
  • Drole Torkar A, Plesnik E, Groselj U, Battelino T, Kotnik P. Carotid Intima-Media Thickness in Healthy Children and Adolescents: Normative Data and Systematic Literature Review. Front Cardiovasc Med 2020;7:597768.
  • Oliveira JL, Aguiar-Oliveira MH, D’Oliveira A Jr, Pereira RM, Oliveira CR, Farias CT, Barreto-Filho JA, Anjos-Andrade FD, Marques-Santos C, Nascimento-Junior AC, Alves EO, Oliveira FT, Campos VC, Ximenes R, Blackford A, Parmigiani G, Salvatori R. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH- naive adults. J Clin Endocrinol Metab 2007;92:4664-4670. Epub 2007 Oct 2
  • Bartke A. Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology 2005;146:3718- 3723. Epub 2005 May 26
  • Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-456.
  • Menezes Oliveira JL, Marques-Santos C, Barreto-Filho JA, Ximenes Filho R, de Oliveira Britto AV, Oliveira Souza AH, Prado CM, Pereira Oliveira CR, Pereira RM, Ribeiro Vicente Tde A, Farias CT, Aguiar-Oliveira MH, Salvatori R. Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation. J Clin Endocrinol Metab 2006;91:2093- 2099. Epub 2006 Mar 7
  • Capalbo D, Mattace Raso G, Esposito A, Di Mase R, Barbieri F, Meli R, Bruzzese D, Salerno M. Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study. Clin Endocrinol (Oxf) 2014;80:856-862. Epub 2014 Jan 16
  • Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer- Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 1997;82:2423-2428.
  • Kuromaru R, Kohno H, Ueyama N, Hassan HM, Honda S, Hara T. Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. J Clin Endocrinol Metab 1998;83:3890-3896.
  • Schaefer GB, Greger NG, Fesmire JD, Blackett PR, Wilson DP, Frindik JP. Lipids and apolipoproteins in growth hormone-deficient children during treatment. Metabolism 1994;43:1457-1461.
  • Nozue H, Kamoda T, Matsui A. Serum resistin concentrations in growth hormone-deficient children during growth hormone replacement therapy. Metabolism 2007;56:1514-1517.
  • Belceanu AD, Bilha SC, Vulpoi C, Branisteanu DD. The impact of growth hormone replacement therapy on adipokines, but not upon Ghrelin. Minerva Endocrinol (Torino) 2021.
  • Edén Engström B, Burman P, Holdstock C, Karlsson FA. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH- deficient patients. J Clin Endocrinol Metab 2003;88:5193-5198.
  • Yano Y, Nakazato M, Toshinai K, Inokuchi T, Matsuda S, Hidaka T, Hayakawa M, Kangawa K, Shimada K, Kario K. Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients. Am J Hypertens 2014;27:727-733. Epub 2013 Dec 21
  • Oliveira-Santos AA, Salvatori R, Nogueira MC, Bueno AC, Barros- Oliveira CS, Leal ÂCGB, Marinho CG, Damascena NP, Oliveira DA, Melo MA, Oliveira CRP, da Costa FO, Dos Santos JSS, Santos PFC, Campos VC, Santos EG, Melo EV, Barbosa MLA, Rocha IES, de Castro M, Aguiar- Oliveira MH. Enteroendocrine Connections in Congenital Isolated GH Deficiency Due to a GHRH Receptor Gene Mutation. J Clin Endocrinol Metab 2019;104:2777-2784.
  • Ciresi A, Pizzolanti G, Leotta M, Guarnotta V, Teresi G, Giordano C. Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children. J Endocrinol Invest 2016;39:1023-1030. Epub 2016 Apr 28
  • López-Siguero JP, López-Canti LF, Espino R, Caro E, Fernández-García JM, Gutiérrez-Macías A, Rial JM, Lechuga JL, Macías F, Martínez-Aedo MJ, Rico S, Rodríguez I, Guillén J, Arroyo FJ, Bernal S, Espigares R, Núñez M, Escribano A, Barrionuevo JL, Gentil J, Barrios V, Fernández-Nistal A, Martos-Moreno GA, Martínez V, Argente J. Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-α and ghrelin levels in growth hormone-deficient children. J Endocrinol Invest 2011;34:300-306. Epub 2010 Jul 13
  • Meazza C, Elsedfy HH, Pagani S, Bozzola E, El Kholy M, Bozzola M. Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment. Horm Metab Res 2014;46:219-223. Epub 2013 Dec 2
  • Pöykkö SM, Kellokoski E, Ukkola O, Kauma H, Päivänsalo M, Kesäniemi YA, Hörkkö S. Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Intern Med 2006;260:43- 52.
  • Rusu CC, Racasan S, Moldovan D, Potra A, Tirinescu D, Budurea C, Orasan R, Patiu IM, Bondor C, Vladutiu D, Delean D, Danu A, Kacso IM. Ghrelin and acyl ghrelin levels are associated with inflammatory and nutritional markers and with cardiac and vascular dysfunction parameters in hemodialysis patients. Int Urol Nephrol 2018;50:1897- 1906. Epub 2018 Jul 13
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
  • Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410.
APA Saygili S, Kocaağa M, Asker Kaya G, şükür m, Bas F, Poyrazoglu S, Bundak R, Darendeliler F (2023). Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone. , 77 - 88. 10.4274/jcrpe.galenos.2022.2022-8-19
Chicago Saygili Seha Kamil,Kocaağa Mehmet,Asker Kaya Gamze,şükür mine,Bas Firdevs,Poyrazoglu Sukran,Bundak Ruveyde,Darendeliler Feyza Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone. (2023): 77 - 88. 10.4274/jcrpe.galenos.2022.2022-8-19
MLA Saygili Seha Kamil,Kocaağa Mehmet,Asker Kaya Gamze,şükür mine,Bas Firdevs,Poyrazoglu Sukran,Bundak Ruveyde,Darendeliler Feyza Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone. , 2023, ss.77 - 88. 10.4274/jcrpe.galenos.2022.2022-8-19
AMA Saygili S,Kocaağa M,Asker Kaya G,şükür m,Bas F,Poyrazoglu S,Bundak R,Darendeliler F Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone. . 2023; 77 - 88. 10.4274/jcrpe.galenos.2022.2022-8-19
Vancouver Saygili S,Kocaağa M,Asker Kaya G,şükür m,Bas F,Poyrazoglu S,Bundak R,Darendeliler F Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone. . 2023; 77 - 88. 10.4274/jcrpe.galenos.2022.2022-8-19
IEEE Saygili S,Kocaağa M,Asker Kaya G,şükür m,Bas F,Poyrazoglu S,Bundak R,Darendeliler F "Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone." , ss.77 - 88, 2023. 10.4274/jcrpe.galenos.2022.2022-8-19
ISNAD Saygili, Seha Kamil vd. "Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone". (2023), 77-88. https://doi.org/10.4274/jcrpe.galenos.2022.2022-8-19
APA Saygili S, Kocaağa M, Asker Kaya G, şükür m, Bas F, Poyrazoglu S, Bundak R, Darendeliler F (2023). Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone. Journal of Clinical Research in Pediatric Endocrinology, 15(1), 77 - 88. 10.4274/jcrpe.galenos.2022.2022-8-19
Chicago Saygili Seha Kamil,Kocaağa Mehmet,Asker Kaya Gamze,şükür mine,Bas Firdevs,Poyrazoglu Sukran,Bundak Ruveyde,Darendeliler Feyza Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone. Journal of Clinical Research in Pediatric Endocrinology 15, no.1 (2023): 77 - 88. 10.4274/jcrpe.galenos.2022.2022-8-19
MLA Saygili Seha Kamil,Kocaağa Mehmet,Asker Kaya Gamze,şükür mine,Bas Firdevs,Poyrazoglu Sukran,Bundak Ruveyde,Darendeliler Feyza Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone. Journal of Clinical Research in Pediatric Endocrinology, vol.15, no.1, 2023, ss.77 - 88. 10.4274/jcrpe.galenos.2022.2022-8-19
AMA Saygili S,Kocaağa M,Asker Kaya G,şükür m,Bas F,Poyrazoglu S,Bundak R,Darendeliler F Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone. Journal of Clinical Research in Pediatric Endocrinology. 2023; 15(1): 77 - 88. 10.4274/jcrpe.galenos.2022.2022-8-19
Vancouver Saygili S,Kocaağa M,Asker Kaya G,şükür m,Bas F,Poyrazoglu S,Bundak R,Darendeliler F Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone. Journal of Clinical Research in Pediatric Endocrinology. 2023; 15(1): 77 - 88. 10.4274/jcrpe.galenos.2022.2022-8-19
IEEE Saygili S,Kocaağa M,Asker Kaya G,şükür m,Bas F,Poyrazoglu S,Bundak R,Darendeliler F "Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone." Journal of Clinical Research in Pediatric Endocrinology, 15, ss.77 - 88, 2023. 10.4274/jcrpe.galenos.2022.2022-8-19
ISNAD Saygili, Seha Kamil vd. "Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone". Journal of Clinical Research in Pediatric Endocrinology 15/1 (2023), 77-88. https://doi.org/10.4274/jcrpe.galenos.2022.2022-8-19